Showing 34,869 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
The search for a cure

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Editor's pick
TheBodyPro
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Cancer

HIV infection worsens cancer outcomes among elderly

Editor's pick
Healio
2 August 2019
Retention & linkage to care

Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds

Editor's pick
TheBodyPro
1 August 2019
Hepatitis & HIV

13% of HIV-positive Europeans who are cured of hepatitis C are reinfected

News
31 July 2019
How HIV works

Could a better understanding of inflammation help research towards an HIV cure?

News
31 July 2019

Miércoles, 31 de julio de 2019

July 2019

Mercoledì 31 luglio 2019

July 2019

Wednesday 31st July 2019

July 2019

Quarta-feira 31 de julho de 2019

July 2019

Mercredi 31 juillet 2019

July 2019

Среда, 31 июля 2019 года

July 2019
PrEP programmes & uptake

Same-day initiation of PrEP feasible and safe in Latin America

News
30 July 2019
Access to healthcare

Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements

Editor's pick
Medicines Patent Pool
30 July 2019
HIV & criminal law

Getting to zero? HIV criminalization and treatment adherence surveillance

Editor's pick
CATIE Blog
30 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
HIV treatment for children & young people

Without frequent viral load monitoring dolutegravir-based regimens not the best choice for African youth on failing ART

News
30 July 2019
Conference announcements & declarations

IAS 2019: A week in review

Editor's pick
International AIDS Society
29 July 2019
Treatment for women

What’s in a pill? Promise, uncertainty, rands, lives & loves … but rights? What the next big thing in HIV treatment for SA shows us

Editor's pick
Bhekisisa
29 July 2019
Activism & civil society

Women activists say the TAC’s time is up

Editor's pick
Health-e
29 July 2019
PrEP science

#IAS2019: PrEP implants could revolutionise HIV prevention

Editor's pick
Health-e
29 July 2019
Undetectable viral load & treatment as prevention

What a U=U Leader Thinks About the CDC’s Updated Data on HIV Risk

Editor's pick
POZ
29 July 2019